Fasting Study of Divalproex Sodium Extended-Release Tablets 500 mg to Depakote ER® Tablets 500 mg

NCT00647712 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Divalproex Sodium Extended-Release Tablets 500 mg
DRUG: Depakote ER® Tablets 500 mg

Sponsor

Mylan Pharmaceuticals Inc